JohnEWagnerMD

Pediatric Hematology & Oncology • Minneapolis, MN

Professor, Pediatrics, University of Minnesota Medical School, Minneapolis

Join to view full profile

Dr. Wagner is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Wagner's full profile

Already have an account?

Office
420 Delaware Street SE
Mayo Mail Code 366 University of Minnesota
Minneapolis, MN 55455
Phone+1 612-626-2961

Fax+1 612-626-4074
Is this information wrong?

Education & Training

Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 1984 - 1987
Duke University HospitalResidency, Pediatrics, 1981 - 1984
Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1981

Certifications & Licensure

MN State Medical License 1991 - 2024
MD State Medical License 1984 - 1991
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Elected Member The American Society for Clinical Investigation, 2000
Elected Member American Association of Physicians

Clinical Trials

T-Cell Depletion in Unrelated Donor Marrow Transplantation Start of enrollment: 1993 Nov 01
Completed
Phase 3
Bone Marrow Transplantation in Treating Patients With Leukemia Start of enrollment: 1996 Apr 01
Withdrawn
Phase 3
Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer Start of enrollment: 1999 Oct 01
Terminated
Not Applicable
Donor Umbilical Cord Blood Transplant By Injection Into the Bone Marrow in Treating Patients With Hematologic Cancer Start of enrollment: 2005 Jun 01
Terminated
Phase 1, Phase 2
HSCT for High Risk Inherited Inborn Errors Start of enrollment: 2006 Sep 01
Completed
Phase 2
Single vs Double Umbilical Cord Blood Transplants in Children With High Risk Leukemia and Myelodysplasia (BMT CTN 0501) Start of enrollment: 2006 Dec 01
Completed
Phase 3
Allogeneic Hematopoietic Stem Cell Transplant For Epidermolysis Bullosa Start of enrollment: 2007 Apr 01
Terminated
Not Applicable
Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic Malignancy Start of enrollment: 2009 Apr 01
Completed
Phase 1
Biochemical Correction of Severe EB by Allo HSCT and "Off-the-shelf" MSCs Start of enrollment: 2010 Jan 01
Completed
Phase 1, Phase 2
MT2013-31: Allo HCT for Metabolic Disorders and Severe Osteopetrosis Start of enrollment: 2014 Jul 10
Recruiting
Phase 2
Hematopoietic Stem Cell Transplant for High Risk Hemoglobinopathies Start of enrollment: 2014 Sep 02
Recruiting
Not Applicable
Join now to see all

Publications & Presentations

PubMed

17 citations
Comparison of haploidentical and umbilical cord blood transplantation after myeloablative conditioning.
John E. Wagner, Karen K. Ballen, Mei-Jie Zhang, Mariam Allbee-Johnson, Chatchada Karanes, Filippo Milano, Michael R. Verneris, Mary Eapen, Claudio G. Brunstein> ;Blood Advances. 2021 Oct 26
6 citations
The role of peripheral nerve signaling in endometriosis.
Stephen Kenneth Godin, John E. Wagner, Pearl S. Huang, Dara Bree> ;FASEB Bioadvances. 2021 Oct 1
22 citations
American Society of Hematology 2021 guidelines for sickle cell disease: Stem cell transplantation
Julie Kanter, Robert I. Liem, F. Bernaudin, Javier Bolaños-Meade, Courtney D. Fitzhugh, Jane S. Hankins, M. Hassan Murad, Julie A. Panepinto, Damiano Rondelli, Shalini...> ;Blood Advances. 2021 Sep 28
57 citations
Standardizing Definitions of Hematopoietic Recovery, Graft Rejection, Graft Failure, Poor Graft Function, and Donor Chimerism in Allogeneic Hematopoietic Cell Transpla...
Mohamed A. Kharfan-Dabaja, Ambuj Kumar, Ernesto Ayala, Mahmoud Aljurf, Taiga Nishihori, Rebecca A. Marsh, Lauri Burroughs, Navneet S. Majhail, A. Samer Al-Homsi, Zaid ...> ;Transplantation and Cellular Therapy. 2021 Aug 1
5 citations
Lymphoid and myeloid immune cell reconstitution after nicotinamide-expanded cord blood transplantation
Coco de Koning, Weiyang Tao, Amelia M. Lacna, Karin van Veghel, Mitchell E. Horwitz, Guillermo Sanz, Madan Jagasia, John E. Wagner, Patrick J. Stiff, Rabi Hanna, Danie...> ;Bone Marrow Transplantation. 2021 Jul 26
5 citations
Multiply restimulated human thymic regulatory T cells express distinct signature regulatory T-cell transcription factors without evidence of exhaustion.
Keli L. Hippen, Scott N. Furlan, Rahul Roychoudhuri, Ena Wang, Yigang Zhang, Mark J. Osborn, Sarah C. Merkel, Sophia Hani, Margaret L. MacMillan, Frank Cichocki, Jeffr...> ;Cytotherapy. 2021 Apr 20
32 citations
First-in-human phase 1 trial of induced regulatory T cells for graft-versus-host disease prophylaxis in HLA-matched siblings.
Margaret L. MacMillan, Keli L. Hippen, David H. McKenna, Diane Kadidlo, Darin Sumstad, Todd E. DeFor, Claudio G. Brunstein, Shernan G. Holtan, Jeffrey S. Miller, Erica...> ;Blood Advances. 2021 Mar 9
6 citations
Phase I Dose-Finding, Safety, and Tolerability Trial of Romiplostim to Improve Platelet Recovery After UCB Transplantation.
Georgios E. Christakopoulos, Todd E. DeFor, Stefanie M Hage, John E. Wagner, Michael A. Linden, Claudio G. Brunstein, Nelli Bejanyan, Michael R. Verneris, Angela R. Smith> ;Transplantation and Cellular Therapy. 2021 Mar 2
4 citations
Low 5-year health care burden after umbilical cord blood transplantation.
Jesus Garcia Garcia, Sonya Grillo, Qing Cao, Claudio G. Brunstein, Mukta Arora, Margaret L. MacMillan, John E. Wagner, Daniel J. Weisdorf, Shernan G. Holtan> ;Blood Advances. 2021 Feb 9
Weight-based mycophenolate mofetil dosing predicts acute GVHD and relapse after allogeneic hematopoietic cell transplantation
Nelli Bejanyan, John Rogosheske, Qing Cao, Aleksandr Lazaryan, Shernan G. Holtan, Celalettin Ustun, Pamala A. Jacobson, Margaret L. MacMillan, Daniel J. Weisdorf, John...> ;European Journal of Haematology. 2021 Feb 1
2 citations
Cytomegalovirus-Specific Immunity Recovers More Slowly after Cord Blood Transplantation Compared with Matched Sibling Donor Allogeneic Transplantation.
Nelli Bejanyan, Irina Vlasova-St. Louis, Hesham Mohei, Qing Cao, Najla El Jurdi, John E. Wagner, Jeffrey S. Miller, Claudio G. Brunstein> ;Transplantation and Cellular Therapy. 2021 Feb 1
7 citations
Consensus opinion on immune-mediated cytopenias after hematopoietic cell transplant for inherited metabolic disorders
Ashish Gupta, Jaap Jan Boelens, Christen L. Ebens, Joanne Kurtzberg, Troy C. Lund, Angela R. Smith, John E. Wagner, Robert Wynn, Bruce R. Blazar, Paul J. Orchard> ;Bone Marrow Transplantation. 2021 Jan 13
6 citations
Outcomes of chronic graft-versus-host disease following matched sibling donor versus umbilical cord blood transplant.
Grigori Okoev, Daniel J. Weisdorf, John E. Wagner, Bruce R. Blazar, Margaret L. MacMillan, Todd E. DeFor, Aleksandr Lazaryan, Najla El Jurdi, Shernan G. Holtan, Claudi...> ;Bone Marrow Transplantation. 2021 Jan 8
9 citations
Prophylactic Foscarnet for Human Herpesvirus 6: Effect on Hematopoietic Engraftment after Reduced-Intensity Conditioning Umbilical Cord Blood Transplantation
Najla El Jurdi, John Rogosheske, Todd E. DeFor, Nelli Bejanyan, Mukta Arora, Veronika Bachanova, Brian C. Betts, Fiona He, Shernan G. Holtan, Murali Janakiram, Samanth...> ;Transplantation and Cellular Therapy. 2021 Jan 1
38 citations
Guidelines for Cord Blood Unit Selection.
Ioannis Politikos, Eric Davis, Melissa Nhaissi, John E. Wagner, Claudio G. Brunstein, Sandra Cohen, Elizabeth J. Shpall, Filippo Milano, Andromachi Scaradavou, Juliet ...> ;Biology of Blood and Marrow Transplantation. 2020 Dec 1
26 citations
Umbilical Cord Blood Transplants: Current Status and Evolving Therapies.
Ashish Gupta, John E. Wagner> ;Frontiers in Pediatrics. 2020 Oct 2
24 citations
Risk score to predict event-free survival after hematopoietic cell transplant for sickle cell disease
Ruta Brazauskas, Graziana Maria Scigliuolo, Hai-Lin Wang, Barbara Cappelli, Annalisa Ruggeri, Courtney D. Fitzhugh, Jane S. Hankins, Julie Kanter, Joerg J Meerpohl, Ju...> ;Blood. 2020 Jul 30
18 citations
Facilitating resolution of life-threatening acute GVHD with human chorionic gonadotropin and epidermal growth factor
Shernan G. Holtan, Andrea Hoeschen, Qing Cao, Mukta Arora, Veronika Bachanova, Claudio G. Brunstein, Jeffrey S. Miller, Armin Rashidi, Arne Slungaard, Celalettin Ustun...> ;Blood Advances. 2020 Apr 14
Erratum: The influence of stem cell source on transplant outcomes for pediatric patients with acute myeloid leukemia(Blood Advances (2019) 3:7 (1118-1128) DOI: 10.1182...
Amy K. Keating, Jurgen Langenhorst, John E. Wagner> ;Blood Advances. 2020 Mar 24
23 citations
Alternative donor transplantation for acute myeloid leukemia in patients aged ≥50 years: Young HLA-matched unrelated or haploidentical donor?
Miguel-Angel Perales, Benjamin Tomlinson, Mei-Jie Zhang, Andrew St. Martin, Amer Beitinjaneh, John Gibson, William J. Hogan, Natasha Kekre, Hillard M. Lazarus, David I...> ;Haematologica. 2020 Jan 31
5 citations
Evaluation of post-thaw CFU-GM: clinical utility and role in quality assessment of umbilical cord blood in patients receiving single unit transplant.
Eiman Hussein, Todd E. DeFor, John E. Wagner, Darin Sumstad, Claudio G. Brunstein, David H. McKenna> ;Transfusion. 2020 Jan 1
66 citations
Cord blood research, banking, and transplantation: achievements, challenges, and perspectives.
Hector Mayani, John E. Wagner, Hal E. Broxmeyer> ;Bone Marrow Transplantation. 2020 Jan 1
25 citations
Bone marrow transplant with post-transplant cyclophosphamide for recessive dystrophic epidermolysis bullosa expands the related donor pool and permits tolerance of non...
Christen L. Ebens, John A. McGrath, Katsuto Tamai, Alain Hovnanian, John E. Wagner, Megan J. Riddle, Douglas R. Keene, Todd E. DeFor, Rebecca Tryon, Mei Chen, David T....> ;The British Journal of Dermatology. 2019 Dec 1
92 citations
Effect of donor type and conditioning regimen intensity on allogeneic transplantation outcomes in patients with sickle cell disease: a retrospective multicentre, cohor...
Mary Eapen, Ruta Brazauskas, Mark C. Walters, Françoise Bernaudin, Khalid Bo-Subait, Courtney D. Fitzhugh, Jane S. Hankins, Julie Kanter, Joerg J Meerpohl, Javier Bola...> ;The Lancet. Haematology. 2019 Nov 1
12 citations
Monocyte Subpopulation Recovery as Predictors of Hematopoietic Cell Transplantation Outcomes.
Lucie M. Turcotte, Qing Cao, Sarah Cooley, Julie M. Curtsinger, Shernan G. Holtan, Xianghua Luo, Ashely Yingst, Daniel J. Weisdorf, Bruce R. Blazar, Jeffrey S. Miller,...> ;Biology of Blood and Marrow Transplantation. 2019 May 1
Join now to see all

Abstracts/Posters

Mgta-456, an Aryl Hydrocarbon Receptor (AHR) Antagonist Based Expansion of CD34+ Hematopoietic Stem Cells (HSC), Permits Selection of Better HLA Matched Cord Blood Uni...
John E. Wagner, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Outcomes of Chronic Graft-Versus-Host Disease (cGVHD) Following Matched Sibling Donor (MSD) Versus Umbilical Cord Blood Transplant (UCBT)
John E. Wagner, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Romiplostim Improves Platelet Recovery after UCB Transplant
John E. Wagner, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Grant Support

Inducible Regulatory T Cells for the Prevention and Treatment of GVHDNational Heart, Lung and Blood Institute2012–Present
First in Human Study to Evaluation the Safety and Tolerability of HSC835Novartis2011–Present
Production Assistance for Cellular TherapiesNational Heart, Lung and Blood Institute2003–Present
Biology and Transplantation of the Human Stem CellNational Cancer Institute1997–Present